Corneal neovascularization.
Nicholas MP, Mysore N.
Exp Eye Res. 2021 Jan;202:108363. doi: 10.1016/j.exer.2020.108363. Epub 2020 Nov 19.
Available Therapeutic Options for Corneal Neovascularization: A Review.
Drzyzga Ł, Śpiewak D, Dorecka M, Wyględowska-Promieńska D.
Int J Mol Sci. 2024 May 17;25(10):5479. doi: 10.3390/ijms25105479.
Corneal neovascularization: updates on pathophysiology, investigations & management.
Sharif Z, Sharif W.
Rom J Ophthalmol. 2019 Jan-Mar;63(1):15-22.
Corneal neovascularization.
Chang JH, Gabison EE, Kato T, Azar DT.
Curr Opin Ophthalmol. 2001 Aug;12(4):242-9. doi: 10.1097/00055735-200108000-00002.
Gene-based antiangiogenic applications for corneal neovascularization.
Liu S, Romano V, Steger B, Kaye SB, Hamill KJ, Willoughby CE.
Surv Ophthalmol. 2018 Mar-Apr;63(2):193-213. doi: 10.1016/j.survophthal.2017.10.006. Epub 2017 Nov 15.
Inflammatory corneal neovascularization: etiopathogenesis.
Clements JL, Dana R.
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):235-45. doi: 10.3109/08820538.2011.588652.
Recent drug therapies for corneal neovascularization.
Liu X, Wang S, Wang X, Liang J, Zhang Y.
Chem Biol Drug Des. 2017 Nov;90(5):653-664. doi: 10.1111/cbdd.13018. Epub 2017 Jun 21.
Management of corneal neovascularization: Current and emerging therapeutic approaches.
Wu D, Chan KE, Lim BXH, Lim DK, Wong WM, Chai C, Manotosh R, Lim CHL.
Indian J Ophthalmol. 2024 May 1;72(Suppl 3):S354-S371. doi: 10.4103/IJO.IJO_3043_23. Epub 2024 Apr 20.
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo.
Zeng Z, Li S, Ye X, Wang Y, Wang Q, Chen Z, Wang Z, Zhang J, Wang Q, Chen L, Zhang S, Zou Z, Lin M, Chen X, Zhao G, McAlinden C, Lei H, Zhou X, Huang J.
Adv Sci (Weinh). 2024 Jul;11(25):e2401710. doi: 10.1002/advs.202401710. Epub 2024 Apr 6.
[Methods of diagnosis and treatment of corneal neovascularization].
Malyugin BE, Isabekov RS, Kalinnikova SY, Antonova OP.
Vestn Oftalmol. 2023;139(4):86-92. doi: 10.17116/oftalma202313904186.
